News coverage about Kindred Healthcare (NYSE:KND) has been trending somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Kindred Healthcare earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned news coverage about the health services provider an impact score of 46.0006510562701 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
A number of equities analysts have issued reports on the company. Mizuho reiterated a “neutral” rating and set a $9.00 price target on shares of Kindred Healthcare in a research report on Monday, July 3rd. Zacks Investment Research downgraded Kindred Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th. BidaskClub downgraded Kindred Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, July 12th. Finally, Deutsche Bank AG decreased their target price on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a research report on Monday, August 7th. Five equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $9.94.
Kindred Healthcare (NYSE:KND) traded down 2.76% during midday trading on Monday, hitting $7.05. The company had a trading volume of 369,277 shares. Kindred Healthcare has a 52-week low of $5.65 and a 52-week high of $11.90. The stock’s 50-day moving average price is $7.78 and its 200-day moving average price is $9.28. The stock’s market cap is $613.48 million.
Kindred Healthcare (NYSE:KND) last posted its earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.03. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the company earned $0.38 EPS. Kindred Healthcare’s revenue was down 4.6% on a year-over-year basis. On average, equities research analysts expect that Kindred Healthcare will post $0.47 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2017/09/18/kindred-healthcare-knd-given-coverage-optimism-score-of-0-05.html.
About Kindred Healthcare
Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.